After Germany’s cabinet greenlit new legislation permitting the recreational use and cultivation of cannabis, predictions have emerged that the rest of Europe, including the UK, may follow suit.
After Germany’s cabinet greenlit new legislation permitting the recreational use and cultivation of cannabis, predictions have emerged that the rest of Europe, including the UK, may follow suit.
Ananda Developments Plc (AQSE: ANA), a developer of cannabinoid medicines, has secured the necessary funding to initiate a trial to test the effectiveness of its cannabidiol oil, MRX1, in treating
Ananda’s ambition is to be a leading provider of high-quality cannabinoid-based medicines for the treatment of complex, chronic inflammatory pain conditions.
Chill Brands Group PLC (LSE: CHLL, OTCQB: CHBRF) has recently declared its intent to enlarge the Chill.com product marketplace via a newly inked agreement.
Ananda Developments (AQSE: ANA) is an AQUIS-listed healthcare company involved in the development of cannabinoid-based medicines with two concurrently running, third-party funded, Phase II randomised control trials (RCTs).
Cellular Goods (LSE: CBX), a UK-based skincare and wellness company providing premium consumer products formulated with lab-produced cannabinoids, is pleased to announce that it has entered into a contract with
In the wake of the MRX Global acquisition, and what this means for the medical cannabis group
Hellenic Dynamics Plc (LSE: HELD) has inked a five-year deal with ELGO-DIMITRA, an Institute of Plant Breeding and Genetic Resources located in Greece, to collaborate on research and projects. ELGO-DIMITRA
Love Hemp, the struggling cannabis supplement company, announced last night that administrators were appointed.
Some marijuana users claim that it makes them feel numb. However, the UK’s newest cannabis companies, it is having the opposite effect.
Hellenic Dynamics could be at the forefront of Europe’s growing multi-billion-euro medical cannabis sector. The European cannabis market is expected to reach €37 billion by 2027, twice the size of